According to a recent study, skin cancer risk may be associated with higher levels of serum 25-hydroxyitamin D (serum 25(OH)D) levels.
Severe chronic hand eczema patients are more willing to make time for treatment
According to a recent study, patients with more severe chronic hand eczema were willing to dedicate a substantial amount of time daily for treatment.
Concomitant methotrexate adds no benefit to PsO treatment compared to adalimumab monotherapy
According to a recent study, treating psoriasis with adalimumab and concomitant methotrexate has no difference in effectiveness and persistence when compared to adalimumab monotherapy.
Patient QoL, disease burden for PsO may be similar whether high or low BSA
According to a recent study, psoriasis patients with low body surface area (BSA) involvement may experience similar quality of life (QoL) and disease burden as patients with high BSA.
Risk factors for anxiety, depression in AD patients identified
In a recent study, researchers have identified specific risk factors for anxiety and depression in atopic dermatitis (AD) patients, including a lower education level and severe pruritus.
Guselkumab effective in scalp PsO across all skin tones
According to a recent study, guselkumab is effective in treating moderate-to-severe scalp psoriasis in patients with Fitzpatrick Skin Types IV through VI.
GPP patients have five times higher mortality risk than those without
According to a recent study, patients with generalized pustular psoriasis (GPP) have a five times higher risk of all-cause mortality at one year than those without GPP.
Pediatric HS patients have increased prevalence of chronic medical, psychiatric comorbidities
According to a recent study, pediatric patients with hidradenitis suppurativa (HS) have an increased prevalence of chronic medical and psychiatric comorbidities when compared to patients without HS.
Study shows stigma drives depression more than disease severity in alopecia patients
According to a recent study, stigma around alopecia causes more depression and anxiety than the disease itself.
Biologic therapy linked to increased risk of superficial fungal infection in PsO patients
According to a recent study, biologic treatment of psoriasis (PsO) can raise the risk of superficial fungal infections in patients, especially with interleukin (IL)-17 inhibitors.
HealthMinute.TV 